"This is a historic moment for 4DMT as we become a Phase 3 company following our initiation of the 4FRONT-1 clinical trial,” said David Kirn, M.D., Co-founder and Chief Executive Officer of 4DMT.

SANTA CLARA, Calif., Feb. 28, 2025 (GLOBE NEWSWIRE) -- AMD (NASDAQ: AMD) today unveiled the highly-anticipated AMD RDNA™ 4 graphics architecture with the launch of the AMD Radeon™ RX 9070 XT and RX ...

Framework has announced a substantial upgrade for the Framework Laptop 13, highlighted by the powerful AMD Ryzen AI 300 ...

It is a beautiful-looking monitor with crisp visuals and solid built, though it comes for a pretty penny.

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...

Framework will ship six- and eight-core Ryzen AI 300 processors on lower-end configurations, most likely the Ryzen AI 5 340 ...

The Apple Mac Studio comes bearing ridiculous power far beyond the needs of the average consumer with a price to match.

The Gigabyte AMD Radeon RX 9070 is part of the new Radeon 9000 GPU lineup. With support for the new RNDA 4 architecture, 3rd ...

Jio Platforms Limited (JPL), together with AMD, Cisco, and Nokia, announced at Mobile World Congress 2025 plans to form an ...

KitGuru was recently able to sit down with Frank Azor, Chief Architect of Gaming Solutions at AMD. In a wide-ranging ...